Related Experiment Video
Updated: Jul 23, 2025
10:26
Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology
Published on: August 18, 2014
26.3K
Adrenoceptors in the Lower Urinary Tract
Martin Hennenberg1, Martin C Michel2
1Department of Urology, University Hospital, LMU Munich, Munich, Germany.
Handbook of Experimental Pharmacology
|July 16, 2023
Summary
Adrenoceptors regulate lower urinary tract (LUT) function. Beta-3 agonists treat overactive bladder, while alpha-1 antagonists manage benign prostatic hyperplasia symptoms, though their precise mechanisms require further elucidation.
Area of Science:
- Pharmacology
- Urology
- Physiology
Background:
- Adrenoceptors are crucial for lower urinary tract (LUT) function.
- They are key targets for treating major LUT diseases.
- Different adrenoceptor subtypes play distinct roles in bladder and urethral function.
Purpose of the Study:
- To review the roles of adrenoceptors in LUT physiology and disease.
- To discuss the mechanisms of action for current adrenoceptor-targeting drugs.
- To clarify the contribution of smooth muscle relaxation to symptom relief in LUT conditions.
Main Methods:
- Literature review of adrenoceptor function in the LUT.
- Analysis of clinical applications of adrenoceptor agonists and antagonists.
- Discussion of cellular and physiological mechanisms involved.
Main Results:
- Beta-3 adrenoceptor agonists (mirabegron, vibegron) relax detrusor smooth muscle, treating overactive bladder.
- Alpha-1 adrenoceptors in the bladder trigone, urethra, and prostate cause contraction.
- Alpha-1 antagonists (tamsulosin) relieve voiding dysfunction in benign prostatic hyperplasia, but the role of smooth muscle relaxation is not fully understood.
Conclusions:
- Adrenoceptors are vital therapeutic targets for LUT disorders.
- Understanding specific adrenoceptor subtypes and their locations is key for effective treatment.
- Further research is needed to fully elucidate the mechanisms of alpha-1 antagonist therapy in LUT conditions.
More Related Videos
Related Concept Videos
01:31Adrenergic Receptors: ɑ Subtype
1.6K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.6K
01:26Adrenergic Receptors: β Subtype
1.7K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.7K
01:22Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
889
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
889
01:27Adrenergic Receptors (Adrenoceptors): Classification
2.7K
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
2.7K
01:30Adrenergic Agonists: Direct-Acting Agents
1.6K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
1.6K
01:19Anatomy of the Genitourinary System II: Bladder and Urethra
138
The lower urinary system consists of the urinary bladder and urethra, which are essential in storing and expelling urine from the body. Together with the internal and external sphincters, these structures work together to regulate urination effectively.Anatomy of the BladderThe urinary bladder is a muscular, stretchable organ behind the pubic bone and in front of the rectum. In females, the bladder is positioned anterior to the vagina and inferior to the uterus, while in males, it is located...
138